Cengild Medical Berhad (KLSE:CENGILD)

Cengild Medical Berhad Income Statement

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	74.93	80	66.82	70.28	64.44	63.47
Revenue Growth (YoY)	-0.59%	19.72%	-4.92%	9.06%	1.53%	62.00%
Cost of Revenue	40.14	43.12	35.75	39.55	38.39	36.79
Gross Profit	34.79	36.87	31.07	30.73	26.05	26.68
Selling, General & Admin	23.41	22.05	17.86	16.24	14.48	12.21
Other Operating Expenses	0.42	-	-	-	-	-
Operating Expenses	24.32	22.54	17.86	16.26	14.48	12.21
Operating Income	10.47	14.33	13.21	14.46	11.57	14.47
Interest Expense	-0.34	-0.39	-0.6	-0.73	-0.85	-1.22
Earnings From Equity Investments	0.87	0.47	-0.35	-	-	-0
Other Non Operating Income (Expenses)	3.59	3.59	4.48	3.65	1.39	0.22
EBT Excluding Unusual Items	14.59	18.01	16.73	17.37	12.11	13.47
Pretax Income	14.59	18.01	16.73	17.37	12.11	13.47
Income Tax Expense	3.47	4.44	4.77	4.09	2.72	3.46
Earnings From Continuing Operations	11.12	13.57	11.97	13.29	9.39	10
Earnings From Discontinued Operations	-1.44	-2.51	-0.89	-	-	-
Net Income	9.69	11.06	11.08	13.29	9.39	10
Net Income to Common	9.69	11.06	11.08	13.29	9.39	10
Net Income Growth	-15.77%	-0.19%	-16.64%	41.50%	-6.13%	153.15%
Shares Outstanding (Basic)	833	833	833	819	644	600
Shares Outstanding (Diluted)	833	833	834	826	645	600
Shares Change (YoY)	-0.02%	-0.11%	1.00%	27.94%	7.56%	4700.00%
EPS (Basic)	0.01	0.01	0.01	0.02	0.01	0.02
EPS (Diluted)	0.01	0.01	0.01	0.02	0.01	0.02
EPS Growth	-15.77%	-0.19%	-17.39%	10.46%	-12.59%	-94.73%
Free Cash Flow	-57.26	-21.18	-2.8	11.78	14.9	12.6
Free Cash Flow Per Share	-0.07	-0.03	-0.00	0.01	0.02	0.02
Dividend Per Share	0.007	0.010	0.007	0.007	0.004	-
Dividend Growth	-27.83%	31.08%	-	100.00%	-	-
Gross Margin	46.43%	46.10%	46.50%	43.72%	40.42%	42.03%
Operating Margin	13.97%	17.91%	19.77%	20.58%	17.95%	22.79%
Profit Margin	12.93%	13.82%	16.58%	18.91%	14.57%	15.76%
Free Cash Flow Margin	-76.41%	-26.48%	-4.19%	16.77%	23.12%	19.85%
EBITDA	15.5	19.39	15.76	16.33	14.56	17.56
EBITDA Margin	20.68%	24.23%	23.58%	23.23%	22.60%	27.67%
D&A For EBITDA	5.03	5.06	2.55	1.87	2.99	3.1
EBIT	10.47	14.33	13.21	14.46	11.57	14.47
EBIT Margin	13.97%	17.91%	19.77%	20.58%	17.95%	22.79%
Effective Tax Rate	23.76%	24.65%	28.48%	23.52%	22.48%	25.72%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.